Parkinson’s Disease (PD) is a complex neurodegenerative disease in which many environmental conditions appear to interact with genetic factors to modify a person’s risk of developing the disease.
Related content
Possible α-synuclein targets for development of therapies for Parkinson’s disease
Overview of three therapeutic strategies targeting alpha-synuclein in the development of disease-modifying treatments for Parkinson’s disease
26.06.2025
Parkinson’s Disease
Disease modification in Parkinson’s disease
Graphical representation of how various treatment strategies can impact disease progression in Parkinson’s disease, from symptom relief to potential cure
26.06.2025
Parkinson’s Disease
Catechol-O-methyltransferase (COMT) inhibitors: mechanism of action
Illustration of how COMT inhibitors increase dopamine availability in Parkinson’s disease by preventing the breakdown of L-DOPA
26.06.2025
Parkinson’s Disease